Phenotype expression in women with CMT1X

Journal of the Peripheral Nervous System

Volumn 16, Issue 2, 2011, Pages 102-107

  Siskind, Carly E ^a   Murphy, Sińead M ^b   Ovens, Richard ^b   Polke, James ^b   Reilly, Mary M ^b   Shy, Michael E ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Charcot Marie Tooth disease; Connexin 32; X chromosome inactivation

Indexed keywords

CONNEXIN 32;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LEUKOCYTE; LONGITUDINAL STUDY; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; SCORING SYSTEM; X CHROMOSOME INACTIVATION; ELECTROPHYSIOLOGY; GENETICS; MIDDLE AGED; NERVE CONDUCTION; PATHOPHYSIOLOGY; PEDIGREE; PHYSIOLOGY; X CHROMOSOME LINKED DISORDER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHARCOT-MARIE-TOOTH DISEASE; CHILD; ELECTROPHYSIOLOGY; FEMALE; GENETIC DISEASES, X-LINKED; HUMANS; MIDDLE AGED; NEURAL CONDUCTION; PEDIGREE; PHENOTYPE; X CHROMOSOME INACTIVATION; YOUNG ADULT;

EID: 80054846499     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2011.00332.x     Document Type: Article

References (19)

1. Allen RC, Zoghbi HY,Moseley AB, Rosenblatt HM, Belmont JW (1992). Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229-1239. (Pubitemid 23001082)
2. Amos-Landgraf JM, Cottle A, Plenge RM, Friez M, Schwartz CE, Longshore J, Willard HF (2006). X chromosome-inactivation patterns of 1,005 phenotypically unaffected females. Am J Hum Genet 79:493-499. (Pubitemid 44384258)
3. Belmont JW (1996). Genetic control of X inactivation and processes leading to X-inactivation skewing. Am J Hum Genet 58:1101-1108. (Pubitemid 26153819)
4. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH (1993). Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262:2039-2042. (Pubitemid 24041884)
5. Dubourg O, Tardieu S, Birouk N, Gouider R, Leger JM, Maisonobe T, Brice A, Bouche P, LeGuern E (2001). Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease. Brain 124:1958-1967. (Pubitemid 32945897)
6. England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF Jr, Lauria G, Miller RG, Polydefkis M, Sumner AJ (2009). Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 72:185-192.
7. Gale RE, Wheadon H, Boulos P, Linch DC (1994). Tissue specificity of X-chromosome inactivation patterns. Blood 83:2899-2905. (Pubitemid 24142722)
8. Hahn AF, Bolton CF, White CM, Brown WF, Tuuha SE, Tan CC, Ainsworth PJ (1999). Genotype/phenotype correlations in X-linked dominant Charcot-Marie-Tooth disease. Ann N Y Acad Sci 883:366-382. (Pubitemid 129495445)
9. Latour P, Gonnaud PM, Ollagnon E, Chan V, Perelman S, Stojkovic T, Stoll C, Vial C, Ziegler F, Vandenberghe A, Maire I (2006). SIMPLE mutation analysis in dominant demyelinating Charcot-Marie-Tooth disease: three novel mutations. J Peripher Nerv Syst 11:148-155. (Pubitemid 43894082)
10. Lin GS, Glass JD, Shumas S, Scherer SS, Fischbeck KH (1999). A unique mutation in connexin32 associated with severe, early onset CMTX in a heterozygous female. Ann N Y Acad Sci 883:481-484. (Pubitemid 129495463)
11. Nakagawa M, Takashima H, Umehara F, Arimura K,Miyashita F, Takenouchi N, Matsuyama W, Osame M (2001). Clinical phenotype in X-linked Charcot-Marie-Tooth disease with an entire deletion of the connexin 32 coding sequence. J Neurol Sci 185:31-37. (Pubitemid 32215499)
12. Naumova AK, Plenge RM, Bird LM, Leppert M, Morgan K, Willard HF, Sapienza C (1996). Heritability of X chromosome - inactivation phenotype in a large family. Am J Hum Genet 58:1111-1119. (Pubitemid 26153821)
13. Nelis E, Van Broeckhoven C, De Jonghe P, Lofgren A, Vandenberghe A, Latour P, Le Guern E, Brice A, Mostacciuolo ML, Schiavon F, Palau F, Bort S, Upadhyaya M, Rocchi M, Archidiacono N, Mandich P, Bellone E, Silander K, Savontaus ML, Navon R, Goldberg-Stern H, Estivill X, Volpini V, Friedl W, Zerres K, Tyson J, Malcolm S, Holmberg B, Holmgren G, Mariman ECM, Gabreels-Festen AAWM, Yapijakis C, Vassilopoulos D, Clark C,Haites N, Hilbert P, Van Malergem L, Rautenstrauss B, Grene H, Mountford R, Mann K, Bettecken T, Burgunder JM, Hanemann CO, Muller HW, Hertz JM, Schorderet DF, Kuntzer T, Wolf C, Kunert E, Muntoni F, Emmeric-Bock P, Orth U, Gal A (1996). Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet 4:25-33. (Pubitemid 26094167)
14. Orstavik KH (2006). Skewed X inactivation in healthy individuals and in different diseases. Acta Paediatr Suppl 95:24-29. (Pubitemid 43739091)
15. Orstavik KH (2009). X chromosome inactivation in clinical practice. Hum Genet 126:363-373.
16. Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME (2011). Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 69:22-33.
17. Sharp A, Robinson D, Jacobs P (2000). Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet 107:343-349.
18. Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M (2005). Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209-1214.
19. Shy ME, Siskind C, Swan ER, Krajewski KM, Doherty T, Fuerst DR, Ainsworth PJ, Lewis RA, Scherer SS, Hahn AF (2007). CMT1X phenotypes represent loss of GJB1 gene function. Neurology 68:849-855. (Pubitemid 46568537)